Mounjaro (Tirzepatide) Weight Loss Injection

Mounjaro (Tirzepatide) Injection is recommended to be injected once a week under the skin of your upper arm, thigh of belly. You should usually repeat the injection on the same day each week. You may need help if injecting it into the upper arm.

You can inject the same area of your body each week, however, make sure to inject into a different site within that area.

You can inject Mounjaro (Tirzepatide) Injection at any time of the day, and it can be done with or without eating a meal. You should try to use this medicine on the same day each week. It is possible to change the injection day if you forget to take it, but make sure that it has been at least 3 days since your last injection. You should then continue to use Mounjaro (Tirzepatide) Injection on that new day.

The normal dosing regiment for Mounjaro begins at the 2.5mg dose. This dose is then gradually increased by 2.5mg every 4 weeks until you are taking 15mg, which is the highest possible dose.

However, it is important to note that dose increases are not mandatory and should only be done if you are tolerating your current dose well. If you would like to remain on a particular dose, please include this information during the online consultation for our prescribers to view.

Important: please do not try to increase your dose earlier than the prescribed protocol. This will not make you lose weight any faster and is likely to cause more side effects.

Below is a chart outlining the usual dosage increase protocol. Your e-Surgery prescriber might sometimes prescribe a different regiment based on side effects and individual factors.

Contact your doctor immediately if you’ve accidentally taken too much Mounjaro (Tirzepatide) Injection.

Taking too much of this medicine can potentially cause low blood sugar and make you feel sick or be sick.

If you forget to take a dose of Mounjaro (Tirzepatide) Injection, you should use it as soon as you remember if it has been 4 days or less since you should’ve had your injection. If it has been more than 4 days since you should’ve had your injection, you should skip the missed dose and then continue as normal, taking the next dose on your usual weekday.

Mounjaro (Tirzepatide) Injection should be kept out of the sight and reach of children. It should be refrigerated. Do not use it if the injection pen has been frozen. The injection pen can be stored unrefrigerated below 30°c for up to thirty days, after which it must be disposed of.

Check the expiry date which is stated on the pen label and the carton. If it has passed the expiry date, which refers to the last day of that month, do not use it.

Mounjaro (Tirzepatide) Injection is for use in adults who have obesity (BMI of 30 kg/m2 or more) or who are overweight (BMI between 27 and 30 kg/m2) and have weight-related health problems like diabetes or high blood pressure. BMI (Body Mass index) measures weight in relation to height.

Mounjaro (Tirzepatide) Injection shouldn’t be used during pregnancy. It is currently not known if this medicine is safe for use during pregnancy. It is recommended to use contraception while using this medicine.

It is also unknown whether this medicine affects breast-feeding. If you are pregnant, think you may be pregnant, plan on having a baby or are breast-feeding, speak to your doctor for advice before using this medicine.

For more information on Mounjaro (Tirzepatide) Injection, our free Ask-a-Pharmacist service can put you in touch with one of our pharmacists who will provide you with professional medical advice. You can also check reputable online sources such as the BNF website.

Mounjaro (Tirzepatide) Injection shouldn’t be taken if you are allergic to any of the ingredients. Inform your doctor of any allergies you have before using this medicine.

For a full list of warnings and precautions and a list of ingredients contained in this medicine, see the patient information leaflet.

Mounjaro (Tirzepatide) Injection shouldn’t be given to children and teenagers under the age of 18.

The time it takes to see weight loss results with Mounjaro (Tirzepatide) Injection can vary from person to person. However, clinical trials have shown that significant weight loss can be achieved within the first few months of treatment. Consistent use and adherence to a healthy diet and exercise plan are important for optimal results.

Certain medications may interact with Mounjaro (Tirzepatide) Injection, potentially affecting its effectiveness or increasing the risk of side effects. It’s crucial to inform your healthcare provider about all medications you’re taking, have taken recently or might take, as well as any non-prescription medications.

While mild nausea is a common side effect of Mounjaro (Tirzepatide) Injection, severe or persistent nausea and vomiting should be addressed. If you experience these symptoms, contact your healthcare provider immediately.

Mounjaro (Tirzepatide) Injection can potentially cause low blood sugar levels, especially when used in combination with other diabetes medications like insulin or sulfonylureas. It’s important to monitor your blood sugar levels closely and be aware of the signs and symptoms of hypoglycaemia.

While taking Mounjaro (Tirzepatide) Injection, it’s recommended to follow a balanced, calorie-controlled diet rich in nutrients. Avoid skipping meals or going for prolonged periods without eating, as this may increase the risk of low blood sugar. Follow the dietary advice given by your doctor or pharmacist.

Yes, Mounjaro (Tirzepatide) Injection is intended for long-term use in the management of obesity and weight-related conditions. However, it’s important to continue following a healthy lifestyle, including regular exercise and a balanced diet, to maintain weight loss achieved with the medication.